The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinomaBradley A. McGregor, Joaquim Bellmunt, Lucia Kwak et al.|Annals of Oncology|2023Cited by 94